Brand Name :
PDP-Procyclidine, Kemadrin
Synonyms :
Class :
Anti-Parkinson Agent and Anticholinergic Agent
Brand Name :
PDP-Procyclidine, Kemadrin
Synonyms :
Class :
Anti-Parkinson Agent and Anticholinergic Agent
Dosage Forms and Strengths:
Elixir, Oral:
Generic: 2.5 mg/5 mL
Tablet, Oral:
Generic: 2.5 mg, 5 mg
Safety and efficacy not established
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
anti-Parkinson Agents may diminish the therapeutic effect of anti-psychotic Agents
may decrease the therapeutic effect when combined with antipsychotic agents
may decrease the therapeutic effect when combined with antipsychotic agents
may decrease the therapeutic effect when combined with antipsychotic agents
may decrease the therapeutic effect when combined with antipsychotic agents
may decrease the therapeutic effect when combined with antipsychotic agents
may decrease the therapeutic effect when combined with antipsychotic agents
may decrease the therapeutic effect when combined with antipsychotic agents
may decrease the therapeutic effect when combined with antipsychotic agents
may decrease the therapeutic effect when combined with antipsychotic agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may diminish the therapeutic effect of anti-parkinson agents
may decrease the therapeutic effect of anti-parkinson agents
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
may decrease the therapeutic effect of antiparkinson agents
may decrease the anti-psychotic therapeutic effect
may enhance the effect of each other
may enhance the effect of each other
may enhance the effect of each other
may enhance the effect of each other
may enhance the effect of each other
May enhance the anticholinergic effect of Anticholinergic Agents
fluticasone furoate umeclidinium and vilanterol
umeclidinium may enhance the anti-cholinergic effect of anti-cholinergic agents
anticholinergic agents decrease the efficacy of levosulpride
anticholinergic agents increase the ulcer-producing effect of potassium citrate
anticholinergic agents increase the effect of constipation of eluxadoline
may increase the anticholinergic effect of anticholinergic agents
may enhance the constipation effect
may enhance the activity of each other
may enhance the ulcerogenic activity
may enhance the effect of each other
may enhance the effect of each other
may enhance the effect of each other
may enhance the effect of each other
may enhance the effect of each other
may increase the anti-cholinergic effect
anticholinergic agents increase the effect of cimetropium
It may reduce the therapeutic effect of gastrointestinal agents
It may reduce the therapeutic effect of gastrointestinal agents
It may reduce the therapeutic effect of gastrointestinal agents
It may reduce the therapeutic effect of gastrointestinal agents
It may reduce the therapeutic effect of gastrointestinal agents
anticholinergic agents may enhance the adverse/toxic effect of opioid agonists
anticholinergic agents may enhance the adverse/toxic effect of opioid agonists
anticholinergic agents may enhance the adverse/toxic effect of opioid agonists
may reduce the therapeutic effect of anticholinergic agents
may reduce the therapeutic effect of anticholinergic agents
may reduce the therapeutic effect of anticholinergic agents
may reduce the therapeutic effect of anticholinergic agents
may reduce the therapeutic effect of anticholinergic agents
may reduce the therapeutic effect of gastrointestinal agents
may reduce the therapeutic effect of gastrointestinal agents
may reduce the therapeutic effect of gastrointestinal agents
may reduce the therapeutic effect of gastrointestinal agents
may reduce the therapeutic effect of gastrointestinal agents
may increase the toxic effects of opioid agonists
may increase the toxic effects of opioid agonists
may increase the toxic effects of opioid agonists
they increase the toxicity of opioid agonists
they increase the toxicity of opioid agonists
may diminish the therapeutic effect of acetylcholinesterase Inhibitors
may diminish the therapeutic effect of acetylcholinesterase Inhibitors
may diminish the therapeutic effect of acetylcholinesterase Inhibitors
may diminish the therapeutic effect of acetylcholinesterase Inhibitors
may diminish the therapeutic effect of acetylcholinesterase Inhibitors
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of antipsychotic agents
may diminish the therapeutic effect of gastrointestinal agents
may diminish the therapeutic effect of gastrointestinal agents
may enhance the adverse/toxic effect of other anticholinergic Agents
acetylcholinesterase Inhibitors may diminish the therapeutic effect of anticholinergic Agents
acetylcholinesterase Inhibitors may diminish the therapeutic effect of anticholinergic Agents
acetylcholinesterase Inhibitors may diminish the therapeutic effect of anticholinergic Agents
acetylcholinesterase Inhibitors may diminish the therapeutic effect of anticholinergic Agents
acetylcholinesterase Inhibitors may diminish the therapeutic effect of anticholinergic Agents
acetylcholinesterase Inhibitors reduce the therapeutic effect of anticholinergic Agents
acetylcholinesterase Inhibitors reduce the therapeutic effect of anticholinergic Agents
acetylcholinesterase Inhibitors reduce the therapeutic effect of anticholinergic Agents
acetylcholinesterase Inhibitors reduce the therapeutic effect of anticholinergic Agents
anti-cholinergic agents may diminish the therapeutic effect of gastrointestinal agents
anti-cholinergic agents may diminish the therapeutic effect of gastrointestinal agents
anti-cholinergic agents may diminish the therapeutic effect of gastrointestinal agents
anti-cholinergic agents may diminish the therapeutic effect of gastrointestinal agents
anti-cholinergic agents may diminish the therapeutic effect of gastrointestinal agents
anticholinergic agents increase the toxicity of topiramate
may enhance the tachycardiac effect
may enhance the tachycardiac effect
may increase the anti-cholinergic effect
may increase the anti-cholinergic effect
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may increase the serum concentration
may enhance the anti-cholinergic effect
may enhance the anti-cholinergic effect
may reduce the therapeutic effect of anti-parkinson agents
may increase the toxic effects of opioid agonists
may increase the analgesic effect of opioid agonist
may increase the anti-cholinergic effect
may increase the toxic effects of opioid agonists
may increase the toxic effects
may increase the toxic effects of CNS depressants
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
may reduce the therapeutic effect of antiparkinson drugs
Adverse drug reactions:
Adverse drug reactions:
Frequency Not Defined
Nausea
Paralytic ileus
Urinary retention
Visual hallucinations
Vomiting
Disorientation
Blurred vision
Confusion
Constipation
Tachycardia
Dry mouth or throat
Hyperthermia
Mydriasis
Psychosis
Pregnancy warnings:
US FDA pregnancy category: Not assigned.
Breastfeeding warnings:
The release of the drug into the human breastmilk is unknown
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits
Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: procyclidine (Rx)
Pronunciation: proe-SYE-kli-deen
Why do we use procyclidine?
procyclidine is an Anticholinergic Agent used to treat Parkinson’s disease and helps decrease muscle stiffness and tremors.